Eli Lilly Pulls The Plug On Antibody Study

The National Institute of Allergy and Infectious Diseases (NIAID) ended a study due to the low likelihood of the treatment's effectiveness for COVID-19 patients. The study involved an antibody treatment used alongside remdesivir, a drug approved for emergency use against the coronavirus.

What new insight or understanding did you gain from this video?